We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
A British alcoholic ready-to-drink company divided into two premium brands: Kalosa Spritz and KÖLD Cocktails. Kold Group have produced great-tasting drinks that are covenant and affordable whilst using 100% natural ingredients. The business is designed to be scalable with the capacity to rapidly grow their distribution in the future. Investment is ought to expand nationally, as well as worldwide. Both brands are available in hundreds of UK retailers and the company exports internationally.
days to go: Expired investment: £39,870
Artisan gin makers putting the city of Exeter into the public eye. Exeter Gin has two brands, a self-named gin and Granny's Garbutt's, which both encompass 5 product ranges. These include Rhubarb Gin, Navy Strength and London Dry. The company originally predicted to sell 500 bottles in their first year, but within the first 10 months of establishment, Exeter Gin sold more than 4,000 bottles and 4,500 miniatures. Their products are sold to restaurants and bars, retailers, wholesalers and online. Funds are being raised to pursue growth opportunities such as redeveloping their website, exporting internationally, showcasing their products on gin tours, increase the number of sale outlets and produce new ranges. Furthermore, Exeter Gin plan to purchase high-grade equipment to maximise their economies of scale whilst reducing overall cost.
days to go: Expired investment: £116,150
A food delivery service offering calorie-counted and high-protein meals for those focused on health and fitness. Gym Food is based in London and is now raising funds to open in three more locations across the city. The company has been achieving average weekly sales of £23k in the November 2017/18 trading period. Gym Food does not have any storefronts, or shop fits and instead trades exclusively via deliveries. The business has received a rating of 4.4 out of 5 on UberEats and 94% on Deliveroo.
days to go: Expired investment: £231,170
One Planet Pizza aim to provide the UK with a range of high quality vegan frozen pizza. One Planet's pizza currently come in 4 Italian style pizza's and can be found in most of the major high street supermarkets.
days to go: Expired investment: £26,824
MET Homes provides an off-the-shelf modern construction method (MMC) for housing, aiming to make MMC financially viable at lower production volumes, which addresses an identified market gap. Their system utilizes 13 pre-engineered and factory-assembled load-bearing wall and floor panels, suitable for constructing residential new builds up to three stories high. With a selection of 13 panels, MET Homes has developed over 50 house types in different widths, lengths, and roof styles, offering versatility for construction projects.
days to go: Expired investment: £110,602
Capital Physio is one of the UK’s fastest growing providers of retail physiotherapy. Since inception in 2012, the group has opened 17 clinics as part of a highly scalable and growth driven business model.  
days to go: Expired investment: £6,210
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph